BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

783 related articles for article (PubMed ID: 23170167)

  • 61. Functional Evolution of the 2009 Pandemic H1N1 Influenza Virus NS1 and PA in Humans.
    Nogales A; Martinez-Sobrido L; Chiem K; Topham DJ; DeDiego ML
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021892
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inducible Guanylate-Binding Protein 7 Facilitates Influenza A Virus Replication by Suppressing Innate Immunity via NF-κB and JAK-STAT Signaling Pathways.
    Feng M; Zhang Q; Wu W; Chen L; Gu S; Ye Y; Zhong Y; Huang Q; Liu S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408175
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Die Another Way: Interplay between Influenza A Virus, Inflammation and Cell Death.
    Laghlali G; Lawlor KE; Tate MD
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32260457
    [No Abstract]   [Full Text] [Related]  

  • 64. Differential Induction of IFN-α and Modulation of CD112 and CD54 Expression Govern the Magnitude of NK Cell IFN-γ Response to Influenza A Viruses.
    Kronstad LM; Seiler C; Vergara R; Holmes SP; Blish CA
    J Immunol; 2018 Oct; 201(7):2117-2131. PubMed ID: 30143589
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections.
    Calzas C; Chevalier C
    Front Immunol; 2019; 10():1605. PubMed ID: 31379823
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulation and functions of NLRP3 inflammasome during influenza virus infection.
    Kuriakose T; Kanneganti TD
    Mol Immunol; 2017 Jun; 86():56-64. PubMed ID: 28169000
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Innate immune responses to influenza A H5N1: friend or foe?
    Peiris JS; Cheung CY; Leung CY; Nicholls JM
    Trends Immunol; 2009 Dec; 30(12):574-84. PubMed ID: 19864182
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Innate immunity to influenza virus infection.
    Iwasaki A; Pillai PS
    Nat Rev Immunol; 2014 May; 14(5):315-28. PubMed ID: 24762827
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Influenza virus N-linked glycosylation and innate immunity.
    York IA; Stevens J; Alymova IV
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30552137
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Double Plant Homeodomain Fingers 2 (DPF2) Promotes the Immune Escape of Influenza Virus by Suppressing Beta Interferon Production.
    Shin D; Lee J; Park JH; Min JY
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28404846
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The pathogenesis of influenza virus infections: the contributions of virus and host factors.
    Fukuyama S; Kawaoka Y
    Curr Opin Immunol; 2011 Aug; 23(4):481-6. PubMed ID: 21840185
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Innate immunity to H5N1 influenza viruses in humans.
    Ramos I; Fernandez-Sesma A
    Viruses; 2012 Dec; 4(12):3363-88. PubMed ID: 23342363
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses.
    Pica N; Iyer A; Ramos I; Bouvier NM; Fernandez-Sesma A; García-Sastre A; Lowen AC; Palese P; Steel J
    J Virol; 2011 Dec; 85(23):12825-9. PubMed ID: 21917963
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Innate immune control and regulation of influenza virus infections.
    McGill J; Heusel JW; Legge KL
    J Leukoc Biol; 2009 Oct; 86(4):803-12. PubMed ID: 19643736
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Non structural protein of avian influenza A (H11N1) virus is a weaker suppressor of immune responses but capable of inducing apoptosis in host cells.
    Mukherjee S; Majumdar S; Vipat VC; Mishra AC; Chakrabarti AK
    Virol J; 2012 Aug; 9():149. PubMed ID: 22866982
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B Viruses.
    Carolan LA; Rockman S; Borg K; Guarnaccia T; Reading P; Mosse J; Kelso A; Barr I; Laurie KL
    J Virol; 2015 Dec; 90(6):2838-48. PubMed ID: 26719259
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Humoral immune responses during asthma and influenza co-morbidity in mice.
    Doorley LA; LeMessurier KS; Iverson AR; Palipane M; Samarasinghe AE
    Immunobiology; 2017 Dec; 222(12):1064-1073. PubMed ID: 28889999
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Uncompromised NK cell activation is essential for virus-specific CTL activity during acute influenza virus infection.
    Liu Y; Zheng J; Liu Y; Wen L; Huang L; Xiang Z; Lam KT; Lv A; Mao H; Lau YL; Tu W
    Cell Mol Immunol; 2018 Sep; 15(9):827-837. PubMed ID: 28413216
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Human Milk Oligosaccharide 2'-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model.
    Xiao L; Leusink-Muis T; Kettelarij N; van Ark I; Blijenberg B; Hesen NA; Stahl B; Overbeek SA; Garssen J; Folkerts G; Van't Land B
    Front Immunol; 2018; 9():452. PubMed ID: 29593719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.